Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
| Revenue (Most Recent Fiscal Year) | $19.37B |
| Net Income (Most Recent Fiscal Year) | $1.48B |
| PE Ratio (Current Year Earnings Estimate) | 18.07 |
| PE Ratio (Trailing 12 Months) | 19.62 |
| PEG Ratio (Long Term Growth Estimate) | 1.93 |
| Price to Sales Ratio (Trailing 12 Months) | 3.47 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.67 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 11.56 |
| Pre-Tax Margin (Trailing 12 Months) | 7.90% |
| Net Margin (Trailing 12 Months) | 6.44% |
| Return on Equity (Trailing 12 Months) | 13.57% |
| Return on Assets (Trailing 12 Months) | 6.56% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.08 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.64 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.56 |
| Inventory Turnover (Trailing 12 Months) | 3.31 |
| Book Value per Share (Most Recent Fiscal Quarter) | $88.92 |
| Earnings per Share (Most Recent Fiscal Quarter) | $2.68 |
| Earnings per Share (Most Recent Fiscal Year) | $12.21 |
| Diluted Earnings per Share (Trailing 12 Months) | $4.22 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 288.90M |
| Free Float | 288.01M |
| Market Capitalization | $67.55B |
| Average Volume (Last 20 Days) | 1.01M |
| Beta (Past 60 Months) | 0.43 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.31% |
| Percentage Held By Institutions (Latest 13F Reports) | 86.97% |
| Annual Dividend (Based on Last Quarter) | $3.80 |
| Dividend Yield (Based on Last Quarter) | 1.63% |